Zobrazeno 1 - 10
of 27
pro vyhledávání: '"C. García-Collado"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Section 4: Clinical Pharmacy Services.
Background According to OMS-2016, myelodysplastic syndrome (MDS) associated with del(5q) is manifested by a transfusion-dependent progressive bone marrow failure, with Lenalidomide acting as the intended drug to treat this syndrome. Purpose To analys
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::26a7a0e8851d44fdba7b3a903c2d2674
https://doi.org/10.1136/ejhpharm-2019-eahpconf.343
https://doi.org/10.1136/ejhpharm-2019-eahpconf.343
Autor:
C Alarcon-Payer, C. García Collado, A Jiménez Morales, M. Jurado Chacón, M. E. Clavero Sánchez
Publikováno v:
HemaSphere. 3:970-971
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7928fad5b9d13f388a416f797052996c
https://doi.org/10.1097/01.hs9.0000567124.09086.b6
https://doi.org/10.1097/01.hs9.0000567124.09086.b6
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
R. López-Sepúlveda, C. Fernández-López, C. García Collado, A. Jiménez Morales, C. Valencia Soto, M. Á. Calleja Hernández
Publikováno v:
Farmacia Hospitalaria, Vol 38, Iss 1, Pp 44-49 (2014)
Purpose: To compare the safety profile of telaprevir (TLV) and boceprevir (BOC) with each other and with those described in clinical trials (CT). Material and methods: Retrospective multicenter observational study. Variables collected: age, sex, type
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doajarticles::4fa1d024a00494834265614e0dcfe191
http://www.aulamedica.es/fh/pdf/1142.pdf
http://www.aulamedica.es/fh/pdf/1142.pdf
Autor:
Consolación Melguizo, Raquel Luque, Cristina Mesas, Gloria Perazzoli, M.J. Gandara, Kevin Doello, Marco Fuel, Raúl Ortiz, R. Garcıá-Fumero, C. García-Collado, Jose Prados
Publikováno v:
Annals of Oncology. 30:v16
Background Cabazitaxel is used in the treatment of metastatic prostate cancer. It is not a substrate of P-glycoprotein, which is involved in cellular detoxification of chemotherapeutic agents and in the expulsion of drugs at blood-brain barrier. Our
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::93e1ba7ed746848c8ff27a8e92721a35
https://doi.org/10.1093/annonc/mdz238.055
https://doi.org/10.1093/annonc/mdz238.055
Autor:
R, López-Sepúlveda, C, Fernández-López, C, García Collado, A, Jiménez Morales, C, Valencia Soto, M Á, Calleja Hernández
Publikováno v:
Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria. 38(1)
To compare the safety profile of telaprevir (TLV) and boceprevir (BOC) with each other and with those described in clinical trials (CT).Retrospective multicenter observational study. Variables collected: age, sex, type of patient (naive, nonresponder
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::5b03be35215f356691944a2ec3b51d2d
https://pubmed.ncbi.nlm.nih.gov/24483859
https://pubmed.ncbi.nlm.nih.gov/24483859
Publikováno v:
Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria. 36(6)
To discover the improvements in logistics, management and satisfaction of the patients after the implantation of a robot of dispensation (RAD) in the external consultations of Pharmacy.Pre-post design: implantation of RAD. The study was conducted on
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::e314d07b560c1b8cc85493bdfd9f1a2e
https://pubmed.ncbi.nlm.nih.gov/23461446
https://pubmed.ncbi.nlm.nih.gov/23461446
Autor:
R López-Sepúlveda, N Martínez-Casanova, C García-Collado, FJ Orantes, CM Valencia Soto, J Pérez-Morales
Publikováno v:
European Journal of Hospital Pharmacy. 22:A3.1-A3
Background Inosine triphosphatase (ITPA) genotyping is used for predicting anaemia in patients with genotype 1 chronic hepatitis C. The AA and CA genotypes have the lowest incidence of anaemia. Purpose To compare the incidence of anaemia, the reducti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::52f5a4fe94adde647a07c3217d4b2b34
https://doi.org/10.1136/ejhpharm-2015-000639.6
https://doi.org/10.1136/ejhpharm-2015-000639.6
Autor:
R López-Sepúlveda, Miguel Ángel Calleja-Hernández, S Sadyrbaeva, C García-Collado, C Fernández-López, C García-Fernández, Caparrós-Romero, N Martínez-Casanova, A Jiménez-Morales
Publikováno v:
European Journal of Hospital Pharmacy. 21:A91.2-A92
Background Boceprevir (BOC) and telaprevir (TLV) have been approved recently for the treatment of chronic hepatitis C virus (HCV) infection but their safety remains to be studied. Purpose To analyse the incidence of adverse events (AEs) in patients t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8e54939c2a3c3c635cd7bf04d4fb51f3
https://doi.org/10.1136/ejhpharm-2013-000436.224
https://doi.org/10.1136/ejhpharm-2013-000436.224